![Trump's tariff war: Who are Asia's winners and losers](https://i-invdn-com.investing.com/news/LYNXMPEB4C07I_S.jpg)
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1056 | 1035 | 1072 | 877 | 1308 | 1801 |
Fund Return | 5.65% | 3.49% | 7.24% | -4.28% | 5.52% | 6.06% |
Place in category | 44 | 49 | 181 | 205 | 164 | 97 |
% in Category | 19 | 28 | 70 | 96 | 90 | 83 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Aktia Capital A | 436.34M | 6.37 | -4.04 | 6.17 | ||
Aktia Capital B | 436.34M | 6.37 | -4.03 | 6.17 | ||
Aktia Solida B | 368.4M | 0.78 | 0.87 | 1.54 | ||
Aktia Solida A | 368.4M | 0.78 | 0.87 | 1.54 | ||
Aktia Secura B | 307.7M | 2.52 | 0.34 | 3.41 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
OP-Pohjoismaat Indeksi II A | 878.23M | 3.81 | 5.26 | 7.15 | ||
OP-Pohjoismaat Indeksi II B | 878.23M | 3.81 | 5.26 | 7.15 | ||
OP-Pohjoismaat Indeksi B | 878.23M | 3.80 | 5.06 | 6.91 | ||
OP-Pohjoismaat Indeksi A | 878.23M | 3.79 | 5.06 | 6.91 | ||
Nordea Pohjoismaat T EUR | 838.09M | 2.76 | 1.86 | 7.30 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 9.38 | 557.5 | -1.50% | |
Atlas Copco A | SE0017486889 | 6.35 | 187.7 | -0.85% | |
Volvo B | SE0000115446 | 3.59 | 327.10 | +0.49% | |
AstraZeneca | GB0009895292 | 3.35 | 11,708.0 | -2.14% | |
EQT AB | SE0012853455 | 3.10 | 370.00 | +1.37% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | BUY |
Summary | Strong Buy | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review